Ascendis Pharma Launches SKYTROFA® (lonapegsomatropin) in Germany for the Once-Weekly Treatment of Children and Adolescents with Growth Hormone Deficiency
COPENHAGEN, Denmark, Sept. 15, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
How to Repair Corrupt Exchange Databases Safely and Minimize Downtime
Veea Announces the VeeaONE Distributed Intelligence Platform, Enabling Cybersecure Sovereign Data Fabrics and Enterprise AI Grids for Physical AI